Bank Of America Corp Gh Research PLC Transaction History

Bank Of America Corp

$1.33 Trillion
Q2 2025

A detailed history of Bank Of America Corp transactions in Gh Research PLC stock. As of the latest transaction made, Bank Of America Corp holds 223 shares of GHRS stock, worth $2,707. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223

Previous 153 45.75%

Holding current value

$2,707

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.66 - $13.79 $606 - $965	70 Added 45.75%	223 $2,000
Q1 2025 May 15, 2025	SELL	$7.91 - $17.99 $126 - $287	-16 Reduced 9.47%	153 $1,000
Q4 2024 Feb 14, 2025	SELL	$6.3 - $10.95 $175,952 - $305,822	-27,929 Reduced 99.4%	169 $1,000
Q3 2024 Nov 14, 2024	BUY	$6.69 - $12.49 $127,424 - $237,897	19,047 Added 210.44%	28,098 $187,000
Q2 2024 Aug 14, 2024	SELL	$10.5 - $14.81 $77,280 - $109,001	-7,360 Reduced 44.85%	9,051 $105,000
Q1 2024 May 15, 2024	BUY	$5.34 - $11.09 $571 - $1,186	107 Added 0.66%	16,411 $174,000
Q4 2023 Feb 14, 2024	BUY	$5.26 - $11.04 $71,178 - $149,393	13,532 Added 488.17%	16,304 $94,000
Q4 2022 Feb 10, 2023	BUY	$9.2 - $13.5 $25,318 - $37,152	2,752 Added 13760.0%	2,772 $26,000
Q2 2022 Aug 12, 2022	SELL	$8.99 - $19.87 $57,158 - $126,333	-6,358 Reduced 99.69%	20 $0
Q1 2022 May 16, 2022	BUY	$15.48 - $23.98 $98,421 - $152,464	6,358 Added 31790.0%	6,378 $116,000
Q4 2021 Feb 08, 2022	SELL	$14.1 - $27.9 $28 - $55	-2 Reduced 9.09%	20 $0
Q3 2021 Nov 15, 2021	BUY	$16.51 - $23.68 $363 - $520	22 New	22 $0

Others Institutions Holding GHRS

# of Institutions

Shares Held

38.5M

Call Options Held

Put Options Held

2.6K

View Full List

About GH Research PLC

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $632M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

More about GHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Gh Research PLC Transaction History